2025-524555-31-00招募中1 期
A Phase I Study using Oncolytic AdenoVirus Immunotherapy with Repeat Administrations in Recurrent GliOblastoma (VIRAGO)
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)2 个研究点 分布在 1 个国家目标入组 18 人开始时间: 2026年10月1日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 18
- 试验地点
- 2
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
Coordinating investigator
Scientific
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
研究点 (2)
Loading locations...
相似试验
尚未招募
1 期
A Study on the Novel Oncolytic Virus Combined With PD-1 Inhibitor in the Treatment of Recurrent High-grade GliomaNCT07472790Beijing Bio-Targeting Therapeutics Technology Co., Ltd15
招募中
1 期
Safety, Tolerability, and Preliminary Efficacy of KD01 Via Intravesical Instillation in Bladder Cancer (BC)NCT07359235Tongji Hospital29
招募中
1 期
Oncolytic virus TILT-123 in combination with lymphocyte-depleting chemotherapy and TILs in the treatment of melanomaMelanoma2024-514092-18-00TILT Biotherapeutics Oy9
尚未招募
不适用
Oncolytic adenovirus therapy as an adjuvant treatment for localised prostate cancer.Oncolytic adenovirus therapy, Localised prostate cancer, Adjuvant treatment, Radical prostatectomyOncolytische adenovirus therapie, Gelokaliseerde prostaatkanker, Adjuvante behandeling, Radicale prostatectomieNL-OMON24928Erasmus MC18
尚未招募
1 期
To Evaluate the Safety and Efficacy of GS1168 Injection in Adult PhenylketonuriaNCT07318909Gritgen Therapeutics Co., Ltd.9